Strategy
MSTR
Coinbase
COIN
Alphabet-A
GOOGL
Alphabet-C
GOOG
Meritage Homes
MTH
US Stock MarketDetailed Quotes
RAPP Rapport Therapeutics
- 9.990
- +2.840+39.72%
Close Mar 4 16:00 ET
- 9.770
- -0.220-2.20%
Post 20:01 ET
365.40MMarket Cap-5.09P/E (TTM)
10.850High6.430Low1.24MVolume6.630Open7.150Pre Close11.96MTurnover8.37%Turnover RatioLossP/E (Static)36.58MShares29.74052wk High1.13P/B148.14MFloat Cap6.43052wk Low--Dividend TTM14.83MShs Float29.740Historical High--Div YieldTTM61.82%Amplitude6.430Historical Low9.628Avg Price1Lot Size
About Rapport Therapeutics Company
Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.
Company Profile
SymbolRAPP
Company NameRapport Therapeutics
Listing DateJun 7, 2024
Issue Price17.00
Founded2022
CEOMr. Abraham N. Ceesay, M.B.A.
MarketNASDAQ
Employees58
Fiscal Year Ends12-31
Address1325 Boylston Street,Suite 401
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02215
Phone1-857-321-8020
Websitehttp://www.rapportrx.com
Company Executives
- Name
- Position
- Salary
- Abraham N. Ceesay, M.B.A.
- Chief Executive Officer and Director
- 2.42M
- Dr. Swamy Yeleswaram, PhD
- Chief Development Officer
- --
- Dr. Bradley S. Galer, M.D.
- Chief Medical Officer
- --
- Kathy Wilkinson
- Chief People Officer
- --
- Cheryl Gault
- Chief Operating Officer
- 1.78M
- Troy A. Ignelzi
- Chief Financial Officer
- 2.13M
- David Bredt, M.D.,PhD
- Chief Scientific Officer and Director
- --
- Dr. Steven M. Paul, M.D.
- Chairman of the Board
- 568.99K
- Raymond Kelleher, M.D.,PhD
- Director
- --
- Dr. John M. Maraganore,PhD
- Director
- --
- Terry-Ann Burrell, M.B.A.
- Director
- --
- Dr. Jeffrey K. Tong, PhD
- Director
- 55.50K
- Dr. Reid M. Huber, PhD
- Director
- 400.26K
- Dr. James I. Healy, M.D.,PhD
- Director
- --
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.